# An Examination of Predictors of Indicators of Response to Letrozole 2.5 mg

> **NCT00291109** · — · COMPLETED · sponsor: **University of Kansas** · enrollment: 40 (—)

## Conditions studied

- Breast Cancer

## Interventions

- **DRUG:** letrozole 2.5 mg

## Key facts

- **NCT ID:** NCT00291109
- **Lead sponsor:** University of Kansas
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2003-01
- **Primary completion:** —
- **Final completion:** 2005-07
- **Target enrollment:** 40 (—)
- **Last updated:** 2008-09-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00291109

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00291109, "An Examination of Predictors of Indicators of Response to Letrozole 2.5 mg". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00291109. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*